Position in ICLR
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$274,990
-$96,710 QoQ
Shares Held
2,485
+17.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $16,598,580 across 18 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
11,336 | $3,077,157 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,702 | $2,357,394 | |
| 3 | GH |
Guardant Health, Inc.
|
11,811 | $1,772,004 | |
| 4 | BDSX |
Biodesix Inc
|
46,989 | $1,059,601 | |
| 5 | DGX |
Quest Diagnostics Inc
|
4,971 | $1,053,603 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
1,981 | $1,042,877 | |
| 7 | XGN |
Exagen Inc.
|
214,721 | $998,452 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
619 | $790,778 |
All Filings in ICLR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $274,990 | 2,485 | Shares | Sole | 2026-05-08 | |
| 2025-09-30 | $371,700 | 2,124 | Shares | Sole | 2025-11-07 | |
| 2024-12-31 | $841,566 | 4,013 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $950,996 | 3,310 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $399,987 | 1,276 | Shares | Sole | 2024-08-15 | |
| 2021-06-30 | $372,491 | 1,802 | Shares | Sole | 2021-08-05 | |
| 2020-09-30 | $414,856 | 2,171 | Shares | Sole | 2020-11-06 | |
| 2020-03-31 | $433,976 | 3,191 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||